AU3421493A - Use of spiperone or spiperone derivatives as immunosuppressant agents - Google Patents
Use of spiperone or spiperone derivatives as immunosuppressant agentsInfo
- Publication number
- AU3421493A AU3421493A AU34214/93A AU3421493A AU3421493A AU 3421493 A AU3421493 A AU 3421493A AU 34214/93 A AU34214/93 A AU 34214/93A AU 3421493 A AU3421493 A AU 3421493A AU 3421493 A AU3421493 A AU 3421493A
- Authority
- AU
- Australia
- Prior art keywords
- spiperone
- derivatives
- immunosuppressant agents
- immunosuppressant
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- DKGZKTPJOSAWFA-UHFFFAOYSA-N spiperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 DKGZKTPJOSAWFA-UHFFFAOYSA-N 0.000 title 2
- 229960003444 immunosuppressant agent Drugs 0.000 title 1
- 239000003018 immunosuppressive agent Substances 0.000 title 1
- 229950001675 spiperone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/815,283 US5290783A (en) | 1990-03-16 | 1991-12-27 | Use of spiperone derivatives as immunosuppressant agents |
US815283 | 1991-12-27 | ||
US831429 | 1992-02-05 | ||
US07/831,429 US5244902A (en) | 1989-08-21 | 1992-02-05 | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
US893536 | 1992-06-04 | ||
US893534 | 1992-06-04 | ||
US07/893,534 US5574041A (en) | 1990-03-16 | 1992-06-04 | Use of spiperone derivatives as immunosuppressant agents |
US07/893,536 US5703088A (en) | 1989-08-21 | 1992-06-04 | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3421493A true AU3421493A (en) | 1993-07-28 |
Family
ID=27505847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU34214/93A Abandoned AU3421493A (en) | 1991-12-27 | 1992-12-23 | Use of spiperone or spiperone derivatives as immunosuppressant agents |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0661972A1 (en) |
JP (1) | JPH08500326A (en) |
AU (1) | AU3421493A (en) |
CA (1) | CA2126678A1 (en) |
WO (1) | WO1993012789A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5703088A (en) * | 1989-08-21 | 1997-12-30 | Beth Israel Deaconess Medical Center, Inc. | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
US5693645A (en) * | 1992-12-23 | 1997-12-02 | Beth Israel Deaconess Medical Center, Inc. | Use of spiperone or spiperone derivatives as immunosuppressant agents |
US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
AU1335397A (en) * | 1995-12-21 | 1997-07-17 | Eli Lilly And Company | Method for treating dermatitis |
AU3809999A (en) * | 1998-05-18 | 1999-12-06 | Novo Nordisk A/S | Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
US6277991B1 (en) | 1998-05-18 | 2001-08-21 | Novo Nordisk A/S | 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
WO2004019921A2 (en) * | 2002-08-29 | 2004-03-11 | University Of Southampton | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
NZ538307A (en) | 2002-09-09 | 2008-04-30 | Janssen Pharmaceutica Nv | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
JP5727139B2 (en) | 2006-11-28 | 2015-06-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap | 3- (3-Amino-2- (R) -hydroxy-propyl) -1- (4-fluoro-phenyl) -8- (8-methyl-naphthalen-1-ylmethyl) -1,3,8-triaza- Spiro [4.5] decan-4-one salt |
WO2008124209A1 (en) | 2007-04-09 | 2008-10-16 | Janssen Pharmaceutica, N.V. | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
JP2020519639A (en) * | 2017-05-12 | 2020-07-02 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Treatment of gastroparesis with triazaspiro[4.5]decanone |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3155669A (en) * | 1962-06-22 | 1964-11-03 | Res Lab Dr C Janssen N V | 2, 4, 8-triaza-spiro (4, 5) dec-2-enes |
US4839342A (en) * | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
CA2065375A1 (en) * | 1989-08-21 | 1991-02-22 | Richard J. Sharpe | Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
EP0520032B1 (en) * | 1990-03-16 | 1998-09-16 | Beth Israel Hospital Association | Use of spiperone as an immunosuppressant and anti-inflammatory agent |
-
1992
- 1992-12-23 AU AU34214/93A patent/AU3421493A/en not_active Abandoned
- 1992-12-23 WO PCT/US1992/011205 patent/WO1993012789A1/en not_active Application Discontinuation
- 1992-12-23 EP EP93902752A patent/EP0661972A1/en not_active Withdrawn
- 1992-12-23 JP JP5511900A patent/JPH08500326A/en active Pending
- 1992-12-23 CA CA002126678A patent/CA2126678A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0661972A4 (en) | 1994-10-27 |
WO1993012789A1 (en) | 1993-07-08 |
CA2126678A1 (en) | 1993-07-08 |
JPH08500326A (en) | 1996-01-16 |
EP0661972A1 (en) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002792A (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
AU4873193A (en) | Use of substituted benzimidazoles | |
AU8274591A (en) | Water soluble derivatives of taxol | |
AU1231492A (en) | Substituted phenyl-1,3 dioxoloquinoline derivatives and their use as antitumor agents | |
AU2588292A (en) | Aminodiesters of rapamycin | |
PL313619A1 (en) | Derivatives of piperydine | |
PL310443A1 (en) | Derivatives of pyrolo-pyridine | |
AU1371992A (en) | Substituted diphenylethylenes and analogues or derivatives thereof | |
EP0586537A4 (en) | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents | |
EG20279A (en) | New derivatives of 3 arylpyrazoles used as fungicides | |
PL306127A1 (en) | Derivatives of epi-epibathydine | |
GB9320744D0 (en) | Oxa and thiadiazole derivatives | |
AU3031092A (en) | Fungicidal 2-amidazolin-5-one and 2-amidazoline-5-thione derivatives | |
AU2866992A (en) | 4'-(n-substituted-n-oxide)staurosporine derivatives | |
AU3421493A (en) | Use of spiperone or spiperone derivatives as immunosuppressant agents | |
AU9049391A (en) | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity | |
AU7638391A (en) | Derivatives of 3'- and 3"-0-desmethylavermectin compounds | |
AU2490492A (en) | Process for the preparation of beta-phenylisoserine derivatives and use thereof | |
AU7978794A (en) | 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use | |
AU2228992A (en) | Thiazolidine derivatives and their use as anti-viral compounds | |
AU5188093A (en) | Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones | |
AU3695293A (en) | Derivatives of adipogenesis inhibitory factor, their preparation and their use | |
AU5184393A (en) | Substituted derivatives of diaminophthalimide | |
AU4740093A (en) | Use of thiadiazole compounds as an antifouling active ingredient | |
HU9403633D0 (en) | 5-(1,2,4-+triazol-1-yl-methyl)-3h-iso-benzofuran-1-one derivatives, their preparation and use as aromatase inhibitors |